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Background
Enhanced eosinophil migration from the blood into the
tissue is a hallmark of bronchial asthma and other allergic
diseases. So far, very little is known how the function of
vascular endothelial cells is modulated in this process.
Our aim was to characterize the role of prostacyclin
(PGI2) in endothelial function and endothelium-eosi-
nophil interaction.
Materials and methods
Cell interaction studies, like adhesion and transmigration
assays, were performed with freshly isolated human blood
eosinophils on confluent layers of human lung microvas-
cular endothelial cells. The changes in endothelial monol-
ayer integrity were detected by means of transendothelial
electrical resistance and by fluorescence microscopy.
Results
Under basal conditions, the major prostaglandin released
by human microvascular endothelial cells is PGI2. Exoge-
nous PGI2 markedly attenuated the migration of isolated
eosinophils through cell-free filters. This effect was pre-
vented by the IP receptor antagonist Cay10441 and the
adenylyl cyclase inhibitor SQ29548. Treatment of
endothelial cells with diclofenac, a non-selective COX
inhibitor, abolished the PGI2  production which was
accompanied by enhanced eosinophil adhesion to
endothelial monolayers. Similarly, the transmigration of
eosinophils through endothelial monolayers was
enhanced by diclofenac. The diclofenac treatment itself
decreased the electrical resistance of endothelial monolay-
ers and compromised the intercellular cell junctions as
visualized by VE-cadherin staining.
Conclusion
Based on these observations, we conclude that the basal
synthesis of PGI2 by endothelial cells can down-regulate
the endothelial adhesion and transmigration of eosi-
nophils. Furthermore, endogenous PGI2  seems to be
important for the maintenance of endothelium barrier
function. These results suggest that PGI2 may have a pro-
tective role in the case of allergic inflammation and pro-
vide a novel explanation for previous observations that IP
knock-out mice show enhanced eosinophilic inflamma-
tion in response to allergen [1].
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